Recursion Provides Updated Guidance on Clinical Trial Starts
Go back to Recursion Provides Updated Guidance on Clinical Trial Starts| (NASDAQ: RXRX) | Delayed: 3.15 +0.11 (3.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $ | |||
| Open | $3.00 | 52 Week Low | $ | |||
| Day High | $3.16 | P/E | N/A | |||
| Day Low | $2.95 | EPS | $ | |||
| Volume | 25,324,767 | |||||
